The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression

Kucukibrahimoglu E., Saygin M. Z., Caliskan M., Kaplan O. K., Unsal C., GÖREN M. Z.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.65, sa.6, ss.571-577, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 65 Sayı: 6
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s00228-009-0650-7
  • Dergi Adı: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.571-577
  • Anahtar Kelimeler: Antidepressant therapy, Biomarker, SSRI, Therapy control, GAMMA-AMINOBUTYRIC-ACID, PERFORMANCE LIQUID-CHROMATOGRAPHY, RAT CEREBRAL-CORTEX, MOOD DISORDERS, ELECTROCONVULSIVE-THERAPY, SULFITE DERIVATIZATION, PREFRONTAL CORTEX, RECEPTOR CHANNELS, CINGULATE CORTEX, RAPHE NUCLEI
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective The aim of this study was to investigate the relationship between plasma glutamate, glutamine and gamma-aminobutyric acid (GABA) levels in female patients with major depression treated with S-citalopram or fluoxetine.